Review: taking Phenergan and Suboxone together


Summary

Drug interactions are reported among people who take Phenergan and Suboxone together. This review analyzes the effectiveness and drug interactions between Phenergan and Suboxone. It is created by eHealthMe based on reports of 81 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Phenergan and Suboxone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Phenergan

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. (latest outcomes from Phenergan 14,168 users)

Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in drug dependence. (latest outcomes from Suboxone 10,334 users)

On Aug, 24, 2016

81 people who take Phenergan, Suboxone are studied.


Number of reports submitted per year:

Phenergan and Suboxone drug interactions.

Drug effectiveness over time:

Phenergan:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)
Suboxone:
  • < 1 month: 80.0% - (4 of 5 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 50.0% - (1 of 2 people)

Drug effectiveness by gender:

Phenergan:
  • female: 66.0% - (2 of 3 people)
  • male: 42.0% - (3 of 7 people)
Suboxone:
  • female: 25.0% - (1 of 4 people)
  • male: 100.0% - (8 of 8 people)

Drug effectiveness by age:

Phenergan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (2 of 2 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Suboxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (2 of 2 people)
  • 20-29: 75.0% - (3 of 4 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 75.0% - (3 of 4 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • insomnia
  • respiratory depression
  • arteriosclerosis
  • bronchopneumonia
  • death
  • decreased appetite
  • gun shot wound
  • hallucination
  • itching
  • pulmonary oedema
1 - 6 months:
  • clamminess
  • sweating fever
  • chest pain
  • endocarditis
  • foetal exposure during pregnancy
  • premature baby
  • renal infarct
  • sweating increased
6 - 12 months:
  • foetal exposure during pregnancy
  • premature baby
  • clamminess
  • sweating fever
  • pneumothorax
  • abdominal pain
  • anaemia
  • crohn's disease
  • diarrhoea
  • haematochezia
1 - 2 years:
  • abdominal hernia
  • blood pressure increased
  • clamminess
  • intestinal obstruction
  • pain
  • pneumonia
  • pre-eclampsia
  • proteinuria
  • pyrexia
  • sweating increased
not specified:
  • nausea
  • vomiting
  • death
  • dehydration
  • injury
  • akathisia
  • dystonia
  • emotional disorder
  • extrapyramidal disorder
  • insomnia

Most common drug interactions by gender *:

female:
  • vomiting
  • nausea
  • death
  • dehydration
  • insomnia
  • pain
  • renal failure
  • somnolence
  • malaise
  • maternal exposure during pregnancy
male:
  • akathisia
  • dyskinesia
  • dystonia
  • emotional disorder
  • extrapyramidal disorder
  • foetal exposure during pregnancy
  • injury
  • pneumothorax
  • tardive dyskinesia
  • tremor

Most common drug interactions by age *:

2-9:
  • accidental drug intake by child
  • drug maladministration
  • drug toxicity
  • sedation
10-19:
  • chest pain
20-29:
  • nausea
  • pancreatitis
  • pancreatitis acute
  • adverse drug reaction
  • endocarditis
  • insomnia
  • renal infarct
  • maternal exposure during pregnancy
  • placenta praevia
  • vomiting
30-39:
  • blood pressure increased
  • deep vein thrombosis
  • pre-eclampsia
  • proteinuria
  • weight increased
40-49:
  • dehydration
  • renal failure
  • somnolence
  • vomiting
  • clamminess
  • nausea
  • confusional state
  • hyporesponsive to stimuli
  • lethargy
  • mania
50-59:
  • vomiting
  • headache
  • pneumonia
  • cough
  • diabetes mellitus
  • dry mouth
  • hyperhidrosis
  • influenza
  • insomnia
  • musculoskeletal pain
60+:
  • androgen deficiency
  • back pain
  • bone pain
  • cardiac disorder
  • chest pain
  • depression
  • diabetes mellitus
  • dyspnoea
  • feeling abnormal
  • multiple fractures

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Phenergan and Suboxone?

Can you answer these questions?

More questions for: Phenergan, Suboxone

You may be interested in these reviews

More reviews for: Phenergan, Suboxone

On eHealthMe, Phenergan (promethazine hydrochloride) is often used to treat nausea. Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.